Skip to main content

International Journal of Clinical Oncology

Ausgabe 4/2014

Inhalt (34 Artikel)

Introduction to Review Articles

Recent advances in radiation oncology

Yasushi Nagata

Review Article

Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective

Katsumasa Nakamura, Tomonari Sasaki, Saiji Ohga, Tadamasa Yoshitake, Kotaro Terashima, Kaori Asai, Keiji Matsumoto, Yoshiyuki Shioyama, Hiroshi Honda

Review Article

Radiobiological basis of SBRT and SRS

Chang W. Song, Mi-Sook Kim, L. Chinsoo Cho, Kathryn Dusenbery, Paul W. Sperduto

Original Article

Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

Xiao-dong Zhu, Fang Su, Zhong-guo Liang, Ling Li, Song Qu, Xia Liang, Qi Wang, Shi-xiong Liang, Long Chen

Original Article

Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer

Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, Jeong-Ok Lee, Tae Min Kim, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo

Original Article

Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy

Gouji Toyokawa, Mitsuhiro Takenoyama, Fumihiko Hirai, Ryo Toyozawa, Eiko Inamasu, Miyako Kojo, Yosuke Morodomi, Yoshimasa Shiraishi, Tomoyoshi Takenaka, Masafumi Yamaguchi, Mototsugu Shimokawa, Takashi Seto, Yukito Ichinose

Original Article

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

Takayuki Ueno, Norikazu Masuda, Takeharu Yamanaka, Shigehira Saji, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Hironobu Sasano, Masakazu Toi

Original Article

Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution

Hirohisa Okabe, Toru Beppu, Akira Chikamoto, Hiromitsu Hayashi, Morikatsu Yoshida, Toshiro Masuda, Katsunori Imai, Kosuke Mima, Shigeki Nakagawa, Hideyuki Kuroki, Hidetoshi Nitta, Takatoshi Ishiko, Daisuke Hashimoto, Yasuyuki Yamashita, Hideo Baba

Original Article

The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma

Lkhagva-Ochir Tovuu, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Yu Saito, Shinichiro Yamada, Michihito Asanoma, Mitsuo Shimada

Original Article

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

Yoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, Daisuke Hashimoto, Akira Chikamoto, Hideyuki Kuroki, Kazuya Sakata, Keita Sakamoto, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Masahiko Hirota, Keiichiro Kanemitsu, Toru Beppu, Hideo Baba

Original Article

MRI T2 hypointensity of metastatic brain tumors from gastric and colonic cancers

Hirofumi Hirano, Shunichi Yokoyama, Shunji Yunoue, Hajime Yonezawa, Kazutaka Yatsushiro, Takako Yoshioka, Ryosuke Hanaya, Hiroshi Tokimura, Kazunori Arita

Original Article

Assessment of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer

Tsutomu Namikawa, Takehiro Okabayshi, Munenobu Nogami, Yasuhiro Ogawa, Michiya Kobayashi, Kazuhiro Hanazaki

Original Article

Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment

Shigenori Kadowaki, Azusa Komori, Yukiya Narita, Sohei Nitta, Kazuhisa Yamaguchi, Chihiro Kondo, Hiroya Taniguchi, Daisuke Takahari, Takashi Ura, Masashi Ando, Kei Muro

Original Article

The safety and efficacy of cisplatin plus gemcitabine in recurrent ovarian cancer

Yui Tomita, Toshiaki Saito, Masao Okadome, Takako Eto, Kazuya Ariyoshi, Kumi Shimamoto

Original Article

A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer

Yukari Ohbuchi, Yasunobu Suzuki, Ikuo Hatakeyama, Yoshifumi Nakao, Atsuya Fujito, Tsuyoshi Iwasaka, Keiichi Isaka

Original Article

Efficacy and safety of advanced renal cell carcinoma patients treated with sorafenib: roles of cytokine pretreatment

Hisanori Suzuki, Toshiro Suzuki, Osamu Ishizuka, Osamu Nishizawa, Manabu Ueno

Original Article

Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis

Masahiro Nozawa, Takeshi Inagaki, Kazuhiro Nagao, Tsukasa Nishioka, Takahiro Komura, Atsunobu Esa, Michio Kitagawa, Masaaki Imanishi, Yasunari Uekado, Takatoshi Ogawa, Hiroshi Kajikawa, Shigeya Uejima, Hideyasu Matsuyama, Isao Hara, Hirotsugu Uemura

Original Article

Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan

Takeshi Hashimoto, Kunihiko Yoshioka, Tatsuo Gondo, Choichiro Ozu, Yutaka Horiguchi, Kazunori Namiki, Yoshio Ohno, Makoto Ohori, Jun Nakashima, Masaaki Tachibana

Original Article

Atopic dermatitis is not a protective factor for melanoma but asthma may be

Enes Hajdarbegovic, Nasirah Atiq, Robert van der Leest, Bing Thio, Tamar Nijsten

Original Article

Treatment strategy for cutaneous apocrine carcinoma

Dai Ogata, Yoshio Kiyohara, Shusuke Yoshikawa, Masako Kasami

Original Article

Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature

Tomoyuki Miyagawa, Hajime Saito, Yoshihiro Minamiya, Kazutaka Mitobe, Shinogu Takashima, Naoko Takahashi, Aki Ito, Kazuhiro Imai, Satoru Motoyama, Junichi Ogawa

Original Article

Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases

Katsuhiro Hayashi, Hiroyuki Tsuchiya, Norio Yamamoto, Toshiharu Shirai, Hideji Nishida, Akihiko Takeuchi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Inatani, Hideki Okamoto, Satoshi Yamada, Hiroko Ikeda, Seiko Sawada-Kitamura, Takayuki Nojima, Akishi Ooi, Takanobu Otsuka

Original Article

Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases

Sadamoto Zenda, Yoshihiro Nakagami, Masamichi Toshima, Satoko Arahira, Mitsuhiko Kawashima, Yoshihisa Matsumoto, Hiroya Kinoshita, Mitsuo Satake, Tetsuo Akimoto

Original Article

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region

Pierre Etienne Heudel, Philippe Cousin, Antoine Lurkin, Claire Cropet, Françoise Ducimetiere, Olivier Collard, Guy De Laroche, Pierre Biron, Pierre Meeus, Philippe Thiesse, Christophe Bergeron, Gualter Vaz, François Mithieux, Fadila Farsi, Yohan Fayet, François-Noel Gilly, Dominic Cellier, Jean-Yves Blay, Isabelle Ray-Coquard

Original Article

Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients

Asmaa M. Zahran, Hosny Badrawy, Abeer Ibrahim

Original Article

Effect of port-care frequency on venous port catheter-related complications in cancer patients

Hatice Odabas, Nuriye Yıldırım Ozdemir, Ipek Ziraman, Sercan Aksoy, Huseyin Abali, Berna Oksuzoglu, Metin Isik, Burak Civelek, Dogan Dede, Nurullah Zengin

Letter to the Editor

Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?

Jon Cacicedo Fernandez de Bobadilla, Pedro Bilbao

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.